New aspirations: The debate on aspiration pneumonia treatment guidelines

Medical Journal of Australia

Volumn 195, Issue 7, 2011, Pages 380-381

  Kwong, Jason C ^a   Howden, Benjamin P ^a   Charles, Patrick G P ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; METRONIDAZOLE; PENICILLIN G; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ABSCESS; ARTICLE; ASPIRATION PNEUMONIA; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BACTEROIDES; BULBAR PARALYSIS; DISEASE SEVERITY; DRUG USE; ENTEROBACTERIACEAE; FUSOBACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; NEUROTOXICITY; NONHUMAN; PANCREATITIS; PATHOGENESIS; PEPTOSTREPTOCOCCUS; PRACTICE GUIDELINE; PREVOTELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; AUSTRALIA;

ANTI-INFECTIVE AGENTS; AUSTRALIA; HUMANS; METRONIDAZOLE; PNEUMONIA, ASPIRATION; PRACTICE GUIDELINES AS TOPIC;

EID: 84856386645     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.10298     Document Type: Article

References (23)

1. Johnson PDR, Irving LB, Turnidge JD. Practice essentials - infectious diseases. 3: Community-acquired pneumonia. Med J Aust 2002; 176: 341-347.
2. Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited, 2010.
3. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 Supp 3: 1-55.
4. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: S27-S72.
5. Teramoto S, Fukuchi Y, Sasaki H, et al. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 2008; 56: 577-579.
6. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665-671.
7. Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a pro-tected specimen brush and quantitative cultures. Intensive Care Med 1993; 19: 279-284.
8. Ebihara S, Ebihara T, Yamanda S, Kohzuki M. Bacteriology of aspiration pneumonia due to delayed triggering of the swallowing reflex in elderly patients [poster abstract]. Am J Respir Crit Care Med 2010; 181: A6176.
9. Lanspa MJ, Li Y, Brown S, et al. Examining infectious pathogens in health-care associated aspiration pneumonia and community acquired aspiration pneumonia [poster abstract]. Am J Respir Crit Care Med 2011; 183: A4858.
10. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974; 56: 202-207.
11. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia: a prospective study of community- and hospital-acquired cases. Ann Intern Med 1974; 81: 329-331.
12. Cesar L, Gonzalez CCL, Calia FM. Bacteriologic flora of aspiration-induced pulmonary infections. Arch Intern Med 1975; 135: 711-714.
13. Bartlett JG, Gorbach SL. Treatment of aspiration pneumonia and primary lung abscess: penicillin G vs clindamycin. JAMA 1975; 234: 935-937.
14. El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167: 1650-1654.
15. Marik PE, Careau P. The role of anaerobes in patients with ventilator-assoc iated pneumonia and aspiration pneumonia: a prospective study. Chest 1999; 115: 178-183.
16. Chua K, Howden BP. Metronidazole. In: Grayson ML, Crowe SM, McCarthy JS, et al, editors. Kucers' the use of antibiotics. 6th ed. London: ASM Press, 2010: 1211-1237.
17. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 2000; 181: 1830-1833.
18. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180: 384-390.
19. Launay A, Ballard SA, Johnson PDR, et al. Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother 2006; 50: 1054-1062.
20. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus fa ecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
21. Bhalla A, Pultz NJ, Ray AJ, et al. Anti anaerobic antibiotic therapy p romotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003; 24: 644-649.
22. Donskey CJ, Chowdhry TK, Hecker M T, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925-1932.
23. Padiglione AA, Wolfe R, Grabsch EA, et al. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection co n t r o l p r oc ed u r e s. Antimicrob Agents Chemother 2003; 47: 2492-2498.